NICOLE PACHECO: Open Payments
NPI 1477105088 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 15 payments from 11 companies in 2025. Trend: 2023 $312 · 2024 $170 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $255 |
| NxStage Medical, Inc. | 2 | $208 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| AKEBIA THERAPEUTICS INC | 1 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $29 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
| CorMedix Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: TAVNEOS, LOKELMA, Vafseo, LIBERTY SELECT CYCLER, NXSTAGE SYSTEM ONE, Kerendia, Rivfloza, KRYSTEXXA.
Industry payments across NM — which companies pay providers there.
